Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 442 | 314 | 334 | 0 | 0 |
| Gross Profit | 442 | 314 | 334 | N/A | N/A |
| Operating Expenses | 6,661 | 5,613 | 3,628 | 3,122 | 3,263 |
| Operating Income | -6,219 | -5,299 | -3,294 | -3,122 | -3,263 |
| Interest Expense | 0 | -1 | 4 | 3 | 3 |
| Other Income | 8 | 0 | 0 | 1 | 0 |
| Pre-tax Income | -6,211 | -5,299 | -3,298 | -3,124 | -3,267 |
| Income Tax | 0 | N/A | 0 | 2 | 5 |
| Net Income Continuous | -6,211 | -5,299 | -3,297 | -3,127 | -3,272 |
| Net Income | $-6,211 | $-5,299 | $-3,298 | $-3,127 | $-3,267 |
| EPS Basic Total Ops | -9.01 | -2.10 | -1.50 | -2.10 | -2.10 |
| EPS Basic Continuous Ops | -0.98 | -1.96 | -1.48 | -1.83 | -1.94 |
| EPS Diluted Total Ops | -9.01 | -2.10 | -1.50 | -2.10 | -2.10 |
| EPS Diluted Continuous Ops | -0.98 | -1.96 | -1.48 | -1.83 | -1.94 |
| EBITDA(a) | $-6,179 | $-5,273 | $-3,268 | $-3,096 | $-3,316 |